´ëÇÑ°ñ´Ù°øÁõÇÐȸ ±¹Á¦Çмú´ëȸ ICO2021 (3ÀÏÂ÷) : 2021-11-07±³À°ÀÏÀÚ : 2021-11-07
±³À°Àå¼Ò : ¼¿ïµå·¡°ï½ÃƼȣÅÚ
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà)´ëÇÑ°ñ´Ù°øÁõÇÐȸ ±¹Á¦Çмú´ëȸ ICO2021 (3ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑ°ñ´Ù°øÁõÇÐȸ
´ã´çÀÚ : ¿À¼ºÈñ
¿¬¶ôó : 02-777-9896
À̸ÞÀÏ :
work@work ±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤½Å°Ç°ÀÇÇаú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаúÀÇ»çÇÐ, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥
Âü¼®¿¹»óÀοø : 80¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 12 ½Ã°£ 55ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í »çÀüµî·Ï : Àü¹®ÀÇ $100, °£È£»ç Àü°øÀÇ $50ÇöÀå µî·Ï : Àü¹®ÀÇ $120, °£È£»ç Àü°øÀÇ $70
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 09:00~09:20 Clinical implication of osteoporosis in surgical treatment of spinal disorders Kwang-Sup Song (Korea)(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 09:20~09:40 Clinical implication of sarcopenia for spinal disorders Hideaki Ishibashi (Japan / JOS)(INA Hospital)
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 09:40~10:00 Complicated osteoporotic spinal fractures Prevalence and its treatments Hyoung-yeon Seo (Korea)(Àü³²ÀÇ´ë)
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 10:00~10:20 Adjuvant anti-osteoporosis treatment following hip fractures Kee Hyung Rhyu (Korea)(°æÈñÀÇ´ë)
Åä·Ð 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 10:20~10:35 Discussion ()
ÈÞ½Ä 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 10:35~10:55 Coffee Break ()
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 10:55~11:25 Treatment of high risk patients: the role of romosozumab Felicia Cosman(Columbia University College of Physicians and Surgeons)
Åä·Ð 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 11:25~11:35 Discussion ()
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 11:35~12:05 Role of the transforming growth factor-©¬ signaling pathway in the regulation of muscle and bone homeostasis Se-Jin Lee( The Jackson Laboratory)
Åä·Ð 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 12:05~12:15 Discussion ()
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 12:15~12:30 The place of denosumab in the sequential therapy of osteoporosis Felicia Cosman(Columbia University College of Physicians and Surgeons)
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 12:30~13:15 ½Ä»ç½Ã°£ ()
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 13:15~13:35 Sarcopenia: Definition and clinical impact in surgeon¡¯s perspective Ho-Joong Kim (Korea)()
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 13:35~13:55 Pathophysiology of sarcopenia Yuuki Imai (Japan/ JSBMR)(Ehime University)
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 13:55~14:15 Linkage between osteoporosis and sarcopenia Young-Sang Kim (Korea)(Â÷ÀÇ´ë)
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 14:15~14:50 Promising treatment and prevention (including out-reach program) Hiroshi Kaji (Japan / JOS)(Kindai University)
Åä·Ð 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 14:35~14:50 Discussion ()
ÈÞ½Ä 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 14:50~15:10 Coffee Break ()
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 15:10~15:30 Long-term treatment strategies for postmenopausal osteoporosis Yoo Mee Kim (Korea)(°¡Å縯°üµ¿ÀÇ´ë)
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 15:30~15:50 How to manage the rebound effect at denosumab discontinuation? Roland Chapurlat (France / ECTS)(Hôpital E Herriot)
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 15:50~16:10 How different is the once-weekly teriparatide daily one? Yasuhiro Takeuchi (Japan)(Toranomon Hospital)
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 16:10~16:30 PTH1 receptor signaling and therapeutic implications Sihoon Lee (Korea)(°¡ÃµÀÇ´ë)
Åä·Ð 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ 3·ë 16:30~16:45 Discussion ()
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 09:00~10:10 Oral Presentation 3 ()
Åä·Ð 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 10:10~10:35 Discussion ()
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 10:35~10:55 Coffee Break ()
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 13:15~13:35 The health impact of premature menopause including osteoporosis Hyuntae Park (Korea)(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 13:35~13:55 Skeletal effects of hormone therapy Unnop Jaisamram (Thailand)(Chulalongkorn University)
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 13:55~14:15 Extraskeletl effects of hormone therapy (and management of adverse effects) Jaeyen Song(Korea)()
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 14:15~14:50 Management of osteopenia : Why? What? When? Dongyoon Lee (Korea)(¼º±Õ°üÀÇ´ë)
Åä·Ð 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 14:35~14:50 Discussion ()
ÈÞ½Ä 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 14:50~15:10 Coffee Break ()
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 15:10~15:30 Muscle mass 10 years PMO Naohisa Miyakoshi (Japan)(Akita University Graduate School of Medicine)
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 15:30~15:50 The effect of different measurement modalities in the association oflean mass with mortality: A systematic review and meta-analysis Gloria Hoi-Yee (Hong Kong)(The Hong Kong Polytechnic University)
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 15:50~16:10 The effectiveness of PGH Tanawat Amphansap (Thailand)(Police General HospitalBangkok Thailand)
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 16:10~16:30 Osteopenia Osteoporosis in Malaysia Swan Sim Yeap (Malaysia)(Subang Jaya Medical Centre)
±³À°½Ã°£ 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 16:30~16:45 Association of height loss with falls and sarcopenia in community-dwelling older women Ryoma Asahi (Japan)(Japan University of Health Sciences)
Åä·Ð 11-07 ¼¿ïµå·¡°ï½ÃƼ 5Ãþ °í±¸·Á·ë 16:45~17:00 Discussion ()